Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:39 PM
Ignite Modification Date:
2025-12-24 @ 7:39 PM
NCT ID:
NCT04664803
Eligibility Criteria:
Inclusion Criteria:
* Patients diagnosed with sinusitis (accompanied with otitis media) at screening, and whose first symptoms occurred within the past 3 weeks
* Symptoms or signs of acute sinusitis persist without improvement for 10 days after onset or symptoms or signs of acute sinusitis initially improve and then worsen within 10 days
Exclusion Criteria:
* Those who have a history of hypersensitivity to cephalosporin, penicillin, or other beta-lactam antibiotics
* Those with a history of allergic rhinitis or other rhinitis
* Those who have been diagnosed with sinusitis more than 3 times within a year
* Have had or scheduled sinus surgery within 1 month
* Creatinine Clearance \< 40 mL/min at screening
* Those whose AST, ALT, and total bilirubin are more than 3 times the upper limit of normal at screening
* Cystic fibrosis patients
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
12 Years
Maximum Age:
75 Years
Study:
NCT04664803
Study Brief:
Protocol Section:
NCT04664803